Help
Posted Mon, Feb, 25,2013
Published today in Clinical Medicine Insights: Oncology is a new review by Erik J Blok, Peter JK Kuppen, Jeroen EM van Leeuwen and Cornelis FM Sier. Read more about this paper below:
Title
Cytoplasmic Overexpression of HER2: a Key Factor in Colorectal Cancer
Abstract
Trastuzumab, a humanized mouse monoclonal antibody directed against HER2 (Human Epidermal Growth Factor Receptor 2), is currently a keystone in the treatment of breast cancer. Meanwhile, trastuzumab has been validated for use in other types of cancer too. But the data on HER2 expression in colorectal cancer are ambiguous, with reported overexpression of HER2 varying between zero and 84%. In this review these studies are evaluated and compared. It shows that many factors influence the determination of HER2-expression, especially of the intracellular fraction of HER2. It is concluded that although membranous overexpression of HER2 is low in colorectal cancer with only 5% of all patients being positive, a significant proportion of the patients (30%) shows cytoplasmic HER2 overexpression. The clinical impact of enhanced intracellular HER2 is not known, because the nature and origin have not completely been revealed yet. Enlightening this process could be a stepping stone towards targeting of intracellular HER2 as a treatment option.
Click here to learn more about the article, download it and comment
Posted in: Articles Published
News Categories
Thu 08 Oct, 2015
Published This Week (5th - 9th October)Thu 08 Oct, 2015
Biomarker Insights Paper Endorsed by Editor in ChiefWed 07 Oct, 2015
Interview with Professor Jamie DaviesMy experience in publishing in the Journal of Medical Education and Curricular Development was really amazing. The editors were very helpful and their prompt replies made the process easier and faster. Peer reviewers were of high standards, and their remarks were very objective.
Facebook Google+ Twitter
Pinterest Tumblr YouTube